跳至主要内容
临床试验/NL-OMON56294
NL-OMON56294招募中不适用

Coagubility in severe mitral regurgitation: A within-patient evaluation of coagulation status before and after Mitral Valve Transcatheter Edge-to-Edge Repair. - POPular MR

Sint Antonius Ziekenhuis0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - >= 18 years old
  • - Echocardiographic-proven (TTE) moderate or severe MR with a planned M-TEER

排除标准

  • - Patients who are unable to provide informed consent
  • - Active malignancy excluding non-melanoma skin cancer
  • - Active liver disease (ALT, ASP, AP >3x ULN or active hepatitis A, B or C)
  • - Patients using, and unable to omit, nonsteroidal anti-inflammatory drugs,
  • corticosteroids, or hormone replacement therapy
  • - Known coagulopathy
  • - Severe anaemia requiring blood transfusion or thrombocytopenia <50 × 10^9/L
  • - Life expectancy <1 year
  • - Severe kidney failure (eGFR < 30 mL/min)

研究者

相似试验

Coagubility in severe mitral regurgitation: A... | 临床试验